SHAIBATALHAMD AYMEN ABDALKADER → CorMedix Inc. CRMD

Stake: — Shares: — CUSIP: 21900C308 Class: COMMON STOCK, PAR V ALUE $0.001 PER SHARE

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
11 NPORT-P mutual funds holding CUSIP
Elevated short days-to-cover (12.7 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 1 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 12.67

14,665,697 shares short · -4.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-18	Dillione Janet	director	Option exercise	48,909	—	—

Other 13D/G Filings on CorMedix Inc.

Filed	Form	Filer	Stake	Shares
2026-06-12	SCHEDULE 13G/A	SHAIBATALHAMD AYMEN ABDALKADER	—	—	view →
2021-02-11	SC	Elliott Investment Management L.P.	—	—	view →
2019-09-10	SC	ELLIOTT ASSOCIATES, L.P.	—	—	view →
2019-01-04	SC	ELLIOTT ASSOCIATES, L.P.	—	—	view →
2018-01-09	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by SHAIBATALHAMD AYMEN ABDALKADER

Filed	Form	Issuer	Stake	Shares
2026-06-12	SCHEDULE 13G/A	CorMedix Inc. CRMD	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →